Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v17-FR Version v12-EN
Language French English
Date Updated 2019-05-09 2019-01-16
Drug Identification Number 02392232 02392232
Brand name PMS-LOSARTAN-HCTZ PMS-LOSARTAN-HCTZ
Common or Proper name LOSARTAN LOSARTAN
Company Name PHARMASCIENCE INC PHARMASCIENCE INC
Ingredients HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM
Strength(s) 12.5MG 100MG 12.5MG 100MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100 100
ATC code C09DA C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2018-05-30 2018-05-30
Actual start date 2018-06-04 2018-06-04
Estimated end date 2019-05-23 2019-04-23
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments